Search
for
Sort by
Research 31–60 of 1000+
- Alefacept for Severe Alopecia Areata
- Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: A clinical and immunopathologic evaluation
- Partial Response of Severe Alopecia areata to Cyclosporine A
- Treatment of severe alopecia areata with baricitinib
- Methotrexate in Severe Childhood Alopecia Areata: Long-term Follow-up
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Intravenous methylprednisolone pulse therapy in severe alopecia areata
- Adalimumab‐induced scalp psoriasis with severe alopecia
- Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Diagnostic Exercise: Severe Bilaterally Symmetrical Alopecia in a Horse
- Azathioprine-induced Agranulocytosis and Severe Alopecia After Kidney Transplantation Associated With a NUDT15 Polymorphism: A Case Report
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Five Cases of Severe Alopecia Areata Treated with Gagamhwajung-hwan
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Complete hair regrowth in a patient with severe alopecia areata treated with deucravacitinib
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Baricitinib: A Review in Severe Alopecia Areata
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- 378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
- TREATMENT OF SEVERE ALOPECIA AREATA USING METHOTREXATE AS AN ADJUNCTIVE DRUG IN COMBINATION WITH INTRAVENOUS AND ORAL CORTICOSTEROID
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- 75893 Long-term efficacy, complete scalp hair regrowth and normal body hair/nails in adolescents with severe alopecia areata (AA) receiving ritlecitinib up to 3 years in the ALLEGRO clinical trials
- High-Dose Baricitinib for Severe Alopecia Areata with Suboptimal Response to Conventional Therapy: A Real-World Assessment
- BH31 Ritlecitinib for severe alopecia areata: does regional prescribing match national guidance?
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- Effectiveness of baricitinib in severe alopecia areata in real life
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report